This site is intended for healthcare professionals

Phase III MAVORIC trial analyses of Poteligeo shows impact of therapy in T-cell lymphoma.- Kyowa Kirin

Read time: 1 mins
Last updated:7th Dec 2020
Published:7th Dec 2020
Condition: Mycosis Fungoides/T Cell Lymphoma
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest